Showing results (441-450 of 3,318) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|July 20, 2005
Improving treatment of depression in the elderly: two innovations in statistical design of clinical trialsPhilip W LavoriJournal of Clinical Psychopharmacology|July 20, 2005
Trajectories of treatment response in late-life depression: psychosocial and clinical correlatesAriel G Gildengers, Patricia R Houck, Benoit H Mulsant, et al.Journal of Clinical Psychopharmacology|January 17, 2007
Weight gain during a double-blind multidosage clozapine studyJose de Leon, Francisco J Diaz, Richard C Josiassen, et al.Journal of Clinical Psychopharmacology|January 17, 2007
Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging studyYili Shang, Megan A Gibbs, Gerard J Marek, et al.Journal of Clinical Psychopharmacology|January 17, 2007
The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorderJonathan R T Davidson, Kathleen Brady, Thomas A Mellman, et al.Journal of Clinical Psychopharmacology|April 25, 2006
Risperidone-related weight gain: genetic and nongenetic predictorsHsien-Yuan Lane, Yi-Ching Liu, Chieh-Liang Huang, et al.Journal of Clinical Psychopharmacology|April 25, 2006
A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptomsBruce J Kinon, Ilya Lipkovich, S Beth Edwards, et al.Journal of Clinical Psychopharmacology|April 25, 2006
Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patientsMitchell J Barnett, Paul J Perry, Bruce Alexander, et al.Journal of Clinical Psychopharmacology|April 25, 2006
Time course of in vivo 5-HTT transporter occupancy by fluvoxamineAkihiro Takano, Tetsuya Suhara, Tetsuya Ichimiya, et al.Journal of Clinical Psychopharmacology|April 25, 2006
Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trialBaruch Spivak, Rael D Strous, Ginette Shaked, et al.Pageof 332